Focal therapy for prostate cancer

Current Opinion in Urology

Volumn 18, Issue 3, 2008, Pages 269-274

  Polascik, Thomas J ^a   Mouraviev, Vladimir ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cryoablation; High intensity focused ultrasound; Prostate cancer; Radiosurgery; Review; Vascular targeted photodynamic therapy

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CRYOABLATION; DIAGNOSTIC IMAGING; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LASER THERMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIOSURGERY; REVIEW;

BRACHYTHERAPY; CATHETER ABLATION; CRYOTHERAPY; HUMANS; LASER THERAPY; MALE; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS; STEREOTAXIC TECHNIQUES; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 41749116424     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f9b3a5     Document Type: Review

References (46)

1. Cooperberg MR, Lubeck DP, Meng MV, et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22:2141-2149.
2. Jones JS. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 2007; 8:165-172.
3. Barqawi AB, Crawford ED. The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 2007; 13:313-317.
4. Eggener SE, Scardino PT, Carroll PR, et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178:2260-2267.
5. Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol 2006; 16:152-156.
6. Mouraviev V, Mayes JM, Madden JF, et al. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat 2007; 6:91-96.
7. Rukstalis D. Focal cryoablation of the prostate: patient-specific modifications of ultrasound-guided prostatic cryoablation. In: Rukstalis DB, Katz AE, editors. Handbook of urologic cryoablation. London: Informa UK Ltd; 2007. pp. 57-66. This chapter can be considered a significant background paper in the development of the concept of focal cryoablation.
8. Ahmed HU, Pendse D, Illing R, et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4:632-642.
9. Onik G. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation: a review. Technol Cancer Res Treat 2004; 3:365-370.
10. Barzell W, Carey R, Melamed M. The utility of transperineal 3-dimensional pathological mapping in counseling patients seeking expectant management for low volume prostate cancer In: Abstracts of the Seventh Annual Meeting of the Society of Urologic Oncology. Urologic Oncology: Extraordinary Opportunities for Discovery; 1-2 December 2006; Bethesda, Maryland, USA. p. 91.
11. Ahmed HU, Calleary J, Arya M, et al. Re: Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau and L. Lemaitre. J Urol 2006; 176:2432-2437.
12. J Urol 2007; 177:2395; author reply 2395-2396.
13. Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU. Prostate cryoablation: a scientific rationale for future modifications. Urology 2002; 60:19-25.
14. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110:906-910.
15. Cheng L, Jones TD, Pan CX, et al. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol 2005; 18:1022-1026.
16. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy. Urology 2007; 110:906-910.
17. Ohori M, Eastham JA, Koh H, et al. Is focal therapy reasonable in patients with early stage prostate cancer (CaP): an analysis of radical prostatectomy (RP) specimens [abstract]. J Urol 2006; 175 (Suppl):507.
18. Onik G, Narayan P, Vaughan D, et al. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002; 60:109-114.
19. Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176:2432-2437.
20. Nakashima J, Tanimoto A, Kikuchi E, et al. Clinical implications of tumor size and local extent of primary prostatic lesions in prostate cancer patients with metastases: value of endorectal magnetic resonance imaging in patients with metastases. Urology 2007; 70:86-90.
21. Galosi AB, Lugnani F, Muzzonigro G. Salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. J Endourol 2007; 21:1-7.
22. Mouraviev V, Nosnik I, Sun L, et al. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology 2007; 69:311-314.
23. Gowardhan B, Greene D. Cryotherapy for the prostate: an in vitro and clinical study of two new developments; advanced cryoneedles and a temperature monitoring system. BJU Int 2007; 100:295-302.
24. Baust JG, Gage AA, Klossner D, et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat 2007; 6:97-109. This is an excellent example of a translational approach to the clinical application of cryosurgery in a focal setting.
25. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology 2007; 70:117-121.
26. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004; 93:14-18.
27. Cohen J. Cryosurgery of the prostate: techniques and indications. Rev Urol 2004; 6:S21-S26.
28. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005; 103:1625-1630.
29. Miller R, Cohen J Jr. Prostate cryosurgery. In: Rukstalis DB, Katz AE, editors. Handbook of urologic cryoablation. London: Informa UK Ltd; 2007. pp. 39-46.
30. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007; 69:1117-1120. One of the better contemporary case series on focal hemicryoablation of unilateral PCa lesions.
31. Bahn DK, Silverman P, Lee F Sr, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006; 20:688-692.
32. Onik G. Rationale for a 'male lumpectomy,' a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol 2008; 31:98-106.
33. ASTRO. Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37:1035-1041.
34. Trachtenberg J, Bogaards A, Weersink RA, et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol 2007; 178:1974-1979; discussion 1979.
35. Moore CM, Nathan TR, Lees WR, et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (MTHPC) in early prostate cancer. Lasers Surg Med 2006; 38:356-363.
36. Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4:248-252.
37. Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004; 63:297-300.
38. Thueroff S, Knauer K, Chaussy C. 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effect. J Urol 2006; 175 (Suppl):364.
39. Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51:381-387.
40. Madersbacher S, Pedevilla M, Vingers L, et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55:3346-3351.
41. Trachtenberg J, Haider M, Weersink R, et al. Image guided laser thermotherapy for focal ablation of prostate cancer. In: Abstracts of the Eighth Annual Meeting of the Society of Urologic Oncology; 29 November-1 December 2007; Bethesda, Maryland, USA. Urology Oncology: Extraordinary Opportunities for Discovery; 2007. pp. 96-97.
42. Nguyen PL, Zietman AL. High-dose external beam radiation for localized prostate cancer: current status and future challenges. Cancer J 2007; 13:295-301.
43. Cesaretti JA, Kao J, Stone NN, Stock RG. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or =7 years of follow-up. BJU Int 2007; 100:362-367.
44. Ponsky L. Radiosurgery. Contem Urol 2007; 19:20-25.
45. Pawlicki T, Cotrutz C, King C. Prostate cancer therapy with stereotactic body radiation therapy. Front Radiat Ther Oncol 2007; 40:395-406.
46. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42:507-515.